« Return to News | Awards & Advancement

BioHealth names Chappell first entrepreneur-in-residence

Tuesday, March 27, 2012 06:01 AM

BioHealth Innovation (BHI), a new regional private-public partnership, has selected Todd Chappell as the first entrepreneur-in-residence for BHI at the National Institutes of Health (NIH) Office of Technology Transfer (OTT).

Chappell is a venture capital-backed entrepreneurial leader and inventor with more than 10 years of experience in molecular biology research, drug development and life sciences business strategy. Before coming to BHI, he served as the vice president of operations at venture-capital backed Shape Pharmaceuticals, and prior to that he spent nine years at CombinatoRx as director of new products.

As the first entrepreneur-in-residence, Chappell—who will have dual responsibility to both BHI and NIH—will assist OTT in the evaluation of existing technologies, provide an entrepreneurial perspective to OTT in its evaluation of new licensing proposals from start-up companies, advise OTT on opportunities for new ventures based on NIH/FDA technologies, assist with developmental strategies and mentor scientists to help ensure their research becomes commercially valuable.

"There is tremendous start-up potential coming from the 27 institutes of NIH and the FDA research labs,” said Chappell. “With the right strategies and management, new entrepreneurial ventures will be created, and with them, new research, technology and commercially viable health care solutions."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.